Intratumoral T cell activation kills tumors regardless of T cell specificity.

Intratumoral T cell activation can eradicate tumors without tumor-specific T cell receptors, relying on paracrine signaling and innate immune responses.

• Why it matters: This challenges the conventional view that effective immunotherapy depends on tumor-specific T cells, highlighting a potential pathway to treat tumors lacking such responses and overcoming immune evasion.
• What they did: The study activated unexhausted, non-tumor-specific T cells within tumors in mice, analyzing immune recruitment, effector molecules, and pathways involved in tumor destruction, and validated findings in human melanoma data.
• The result: Activation of bystander T cells induced tumor cell death through interferon-γ, tumor necrosis factor, and nitric oxide pathways, predicting better survival in melanoma patients and broadening immunotherapy strategies.